Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Vivo Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and Antigen Presenting (APC) Cells in Rheumatoid Arthritis

NCT01717846 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT01717846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01717846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Vivo Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and Antigen Presenting (APC) Cells in Rheumatoid Arthritis
Lead sponsor
University of California, Los Angeles
Phase
Phase 4
Overall status
Withdrawn
Start date
December 31, 2012
Completion date
November 30, 2014
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

apoptotic dna damage, rheumatoid arthritis, t-cell lymphocytosis